 | Up a level |
Blank, S.; Lordick, F.; Dobritz, M.; Grenacher, L.; Burian, M.; Langer, R.; Roth, W.; Schaible, A.; Becker, K.; Bläker, H.; Sisic, L.; Stange, A.; Compani, P.; Schulze-Bergkamen, H.; Jäger, D.; Büchler, M.; Siewert, J. R.; Ott, K. (2013). A reliable risk score for stage IV esophagogastric cancer. European journal of surgical oncology EJSO, 39(8), pp. 823-830. Elsevier 10.1016/j.ejso.2013.01.005
Cunningham, D.; Langley, R.; Nankivell, M.; Blazeby, J.; Griffin, M.; Crellin, A.; Grabsch, H.; Okines, A.; Goldstein, C.; Falk, S.; Thompson, J.; Krysztopik, R.; Coxon, F.; Pritchard, S.; Langer, R.; Stenning, S.; Alderson, D. (2015). LBA-03 Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). Annals of oncology, 26(Suppl 4), iv117-iv117. Oxford University Press 10.1093/annonc/mdv262.03
